This review focuses on the Anger Regulation and Expression Scale (ARES) which was developed by DiGiuseppe and Tafrate (2011) and published by Multi-Health Systems Inc. The ARES was designed to be a self-report measure of anger expression and regulation in youth aged 10 to 17 years and was intended to be used in screening, individual assessment, and treatment evaluation. The ARES may also be used for research purposes. The ARES includes a full-length and a short version, the ARES(S). The full-length ARES test is a 75 question self-report form. Participants are presented with statements regarding situations in which they feel anger. The test taker indicates whether they find each item representative of their own thoughts, feelings, or actions using the descriptors: "never," " hardly ever," " sometimes," "often," or "always." The development of the ARES was based on research by DiGiuseppe and Tafrate (2011) concerning the construct of anger as a clinical problem. Prior to the ARES, the authors developed the Anger Disorders Scale (ADS), an anger inventory for adults, which provides the foundation for the ARES. The ARES claims to assess more constructs that comprise the experience of anger and more types of anger expression than any other youth measure. The ARES was designed to be clinically relevant in identifying specific patterns of feeling, behavior, and thinking that can be targeted in intervention. The manual provides a review of literature on anger as a clinical disturbance, an explanation of test development, information on ARES administration and interpretation and comprehensive treatment plans based on ARES scores. Overall, the ARES appears to accomplish its intended purpose of measuring the expression and regulation of anger in youth aged 10 to 17 years. The ARES claims to assess more constructs that comprise the experience of anger and more types of anger expression than any other youth measure. Extensive background information that the authors provided concerning development of this test supports this claim.